GAL and hepatocellular carcinoma: Transfection of HCC cells with the RASSF1A gene using Gal-CMCS-Fe3O4-NPs inhibited the growth of tumors and increased the sensitivity of HCC cells to chemotherapy, suggesting the importance of RASSF1A for HCC gene therapy.